Contact

Cross-Reactive CD4+ T Cells Enhance SARS-CoV-2 Immune Responses Upon Infection and Vaccination

Lucie Loyal et.al., medRxiv (2021) - PMID: n.a.

Product(s) used in this publication: PepMix™ Peptide Pools

Abstract
 

n.a.

Stay in touch and be the first to receive the latest news!